Also listed on Tarveda Therapeutics, Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Feb 23, 2037 · High confidence
20-year base term ends Feb 23, 2037
Held by Tva (ABC), LLC
Filed Dec 12, 2019 as application 16/711,577 · Granted Nov 29, 2022
Base term, 20 years from filing
Today
2017
2037
Clock starts
Feb 23, 2017
Feb 23, 2017
Term ends
Feb 23, 2037
Feb 23, 2037
Granted
Nov 29, 2022
Nov 29, 2022
base term
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 10,548,881, to Feb 23, 2037. The term already ends on or before that date, so the cap shortened nothing.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 0 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Feb 23, 2017, when application PCT/US2017/019040, the earliest non-provisional in its chain, was filed (this one was filed Dec 12, 2019) | Feb 23, 2037 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,548,881) | resolves to Feb 23, 2037, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Feb 23, 2037 | High confidence |
This family
| Application PCT/US2017/019040 | PCT application no patent term | no patent term |
| US 10,548,881 | Lapsed on the fee record Feb 2024 | Feb 2024 |
| US 11,510,910 | this patent Feb 2037 | Feb 2037 |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Feb 11, 2020 Reel 51783, frame 222 | Shinde, Rajesh R.; Bilodeau, Mark T.; Wooster, Richard; Kadiyala, Sudhakar | Tarveda Therapeutics, Inc. | Assignment of Assignor's Interest |
| Oct 4, 2021 Reel 57988, frame 232 | Tarveda Therapeutics, Inc. | Oxford Finance LLC | Security Interest |
| Apr 25, 2022 Reel 59788, frame 518 | Tarveda Therapeutics, Inc. | Tva (ABC), LLC | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Feb 2037
Term ends Feb 23, 2037.
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 10,548,881, ends no earlier than this term, so it caps nothing.
Citations
1
later US patent cites this one
That is below the median of utility patents granted in 2022 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.